Display Settings:

Format
Sort by

Send to:

Choose Destination

    Results: 3

    1.

    LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impact.

    Akl EA, Briel M, You JJ, Lamontagne F, Gangji A, Cukierman-Yaffe T, Alshurafa M, Sun X, Nerenberg KA, Johnston BC, Vera C, Mills EJ, Bassler D, Salazar A, Bhatnagar N, Busse JW, Khalid Z, Walter S, Cook DJ, Schünemann HJ, Altman DG, Guyatt GH.

    Trials. 2009 Jun 11;10:40.PMID: 19519891 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial.

    Cukierman-Yaffe T, Gerstein HC, Williamson JD, Lazar RM, Lovato L, Miller ME, Coker LH, Murray A, Sullivan MD, Marcovina SM, Launer LJ; Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Investigators.

    Diabetes Care. 2009 Feb;32(2):221-6.PMID: 19171735 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: results from the ONTARGET/TRANSCEND research programme.

    Cukierman-Yaffe T, Gerstein HC, Anderson C, Zhao F, Sleight P, Hilbrich L, Jackson SH, Yusuf S, Teo K; ONTARGET/TRANSCEND Investigators.

    Diabetes Res Clin Pract. 2009 Mar;83(3):387-93. Epub 2009 Jan 20.PMID: 19157618 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...